drugset / Trial / NCT00687934
Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
An open-label dose escalation study of patients with solid tumors treated with STA-9090 (ganetespib)
Timeline
- Start
- 2007-10
- Primary completion
- 2011-06
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganetespib | Small molecule | 7 mg/m2 | Intravenous |
| Subject | Ganetespib | Small molecule | 150 mg/m2 | Intravenous |
| Subject | Ganetespib | Small molecule | 200 mg/m2 | Intravenous |
| Subject | Ganetespib | Small molecule | 216 mg/m2 | Intravenous |
| Subject | Ganetespib | Small molecule | 259 mg/m2 | Intravenous |